Macrophages Regulate Unilateral Ureteral obstruction-Induced Renal Lymphangiogenesis through C-C Motif Chemokine Receptor 2-Dependent Phosphatidylinositol 3-Kinase-AKT-Mechanistic Target of Rapamycin Signaling and Hypoxia-Inducible Factor-1α/Vascular Endothelial Growth Factor-C Expression
Macrophages Regulate Unilateral Ureteral obstruction-Induced Renal Lymphangiogenesis through C-C Motif Chemokine Receptor 2-Dependent Phosphatidylinositol 3-Kinase-AKT-Mechanistic Target of Rapamycin Signaling and Hypoxia-Inducible Factor-1α/Vascular Endothelial Growth Factor-C Expression
复制标题
巨噬细胞通过 C-C 基序趋化因子受体 2 依赖性磷脂酰肌醇 3-激酶-AKT 雷帕霉素信号传导和缺氧诱导因子 1 的机制靶标调节单侧输尿管梗阻诱导的肾淋巴管生成
DOI:
10.1016/j.ajpath.2017.04.007
复制
发表时间:
2017-08-01
影响因子:
6
通讯作者:
Wang, Cong-Yi
中科院分区:
文献类型:
--
作者:
Guo, Yan-Chao;Zhang, Meng;Wang, Cong-Yi
Lymphangiogenesis occurs during renal fibrosis in patients with chronic kidney diseases and vascular endothelial growth factor (VEGF)-C is required for the formation of Lymphatic vessels; however, the underlying mechanisms remain unclear. We demonstrate that macrophages can regulate unilateral ureteral obstruction (UUO)-induced renal lymphangiogenesis by expressing high levels of VEGF-C by C-C motif chemokine receptor 2 (CCR2)-mediated signaling. Mice deficient in Ccr2 manifested repressed lymphangiogenesis along with attenuated renal injury and fibrosis after UUO induction. The infiltrated macrophages after UUO induction generated a microenvironment in favor of lymphangiogenesis, which likely depended on Ccr2 expression. Mechanistic studies revealed that CCR2 is required for macrophages to activate phosphatidylinositol 3-kinase (PI3K)-AKT-mechanistic target of rapamycin (mTOR) signaling in response to its ligand monocyte chemoattractant protein 1 stimulation, whereas hypoxia-inducible factor (HIF)-1 alpha is downstream of PI3K-AKT-mTOR signaling. HIF-1 alpha directly bound to the VEGF-C promoter to drive its expression to enhance lymphangiogenesis. Collectively, we characterized a novel regulatory network in macrophages, in which CCR2 activates PI3K-AKT-mTOR signaling to mediate HIF-1 alpha expression, which then drives VEGF-C expression to promote lymphangiogenesis.